Related Experiment Videos
Organic impairment in polydrug users: risk factors
The American Journal of Psychiatry
|February 1, 1978
Summary
Polydrug users often experience lasting neuropsychological deficits, with 37% showing impairment shortly after treatment. This cognitive impairment, linked to CNS depressant and opiate use, may persist long-term.
Area of Science:
- Neuroscience
- Psychology
- Addiction Medicine
Background:
- Polydrug use is a complex issue with significant public health implications.
- Neuropsychological deficits are a known consequence of substance abuse.
- Understanding the persistence and correlates of these deficits is crucial for effective treatment.
Purpose of the Study:
- To assess the prevalence and duration of neuropsychological deficits in polydrug users.
- To identify factors associated with polydrug-related organic impairment.
- To compare neuropsychological status in polydrug users with psychiatric patients and nonpatients.
Main Methods:
- A national collaborative study involving 151 polydrug users.
- Utilized the Halstead-Reitan Neuropsychological Battery for assessment.
- Follow-up assessments were conducted at two to three weeks and three months post-treatment entry.
Main Results:
- 37% of polydrug users exhibited neuropsychological deficits at two to three weeks, and 34% at three months.
- Deficit rates were higher than in psychiatric patients (26-27%) and nonpatients (8-4%).
- Extensive CNS depressant and opiate use correlated with increased deficits; older, less-educated individuals with adverse histories were more vulnerable.
Conclusions:
- Polydrug use is associated with significant and potentially long-lasting neuropsychological impairment.
- Cognitive deficits in polydrug users may persist beyond the initial treatment period.
- Factors such as substance type, age, education, and medical history influence the likelihood and severity of impairment.